Pseudolycorine chloride ameliorates Th17 cell-mediated central nervous system autoimmunity by restraining myeloid-derived suppressor cell expansion.
Gan ZhangXinying ZhuFan YangJuan LiXiao LengChun-Fen MoLi-Mei LiYantang WangPublished in: Pharmaceutical biology (2022)
PLY may be an excellent candidate for the treatment of MS and other autoimmune diseases.